Vaccine skepticism emerges as early test for Biden

The incoming Biden administration will face an immediate challenge persuading a skeptical American public to take a COVID-19 vaccine when one becomes widely available.Health officials, including the nation’s top infectious…

Continue Reading Vaccine skepticism emerges as early test for Biden
EC announces new Pharmaceutical Strategy for Europe

The European Commission (EC) has today adopted a Pharmaceutical Strategy for Europe to ensure that patients have access to innovative and affordable medicines and to support the competitiveness, innovative capacity and sustainability…

Continue Reading EC announces new Pharmaceutical Strategy for Europe
Pandemic Data Is About to Go Sideways

Editor’s Note: The Atlantic is making vital coverage of the coronavirus available to all readers. Find the collection here. Recently, over the course of just one week, the Houston Health…

Continue Reading Pandemic Data Is About to Go Sideways
A Tragic Beginning to the Holiday Season

Editor’s Note: The Atlantic is making vital coverage of the coronavirus available to all readers. Find the collection . City health officials on Wednesday . Hospitals in Utah are approaching…

Continue Reading A Tragic Beginning to the Holiday Season
Phase II trial to study anti-COVID-19 mAb CT-P59 completes enrolment

Celltrion Group has announced the completion of enrolment of 327 patients with mild-to-moderate symptoms of SARS-CoV-2 infection in the global Phase II clinical trial of CT-P59, an anti-COVID-19 monoclonal antibody (mAb) treatment candidate. The company anticipates submission for emergency use authorisation (EUA)…

Continue Reading Phase II trial to study anti-COVID-19 mAb CT-P59 completes enrolment
Happy Thanksgiving from Patent Docs

The authors and contributors of Patent Docs wish their readers and families a Happy Thanksgiving. It is also our hope that all of our readers, along with their families and…

Continue Reading Happy Thanksgiving from Patent Docs
Overnight Health Care: Biden team to begin getting COVID briefings | Fauci says he would ‘absolutely’ serve on Biden’s COVID task force | Major glove factories close after thousands test positive for COVID-19

Welcome to Wednesday’s Overnight Health Care. Programming note: We will not be publishing a newsletter Thursday or Friday. We will return as usual Monday, Nov. 30.In today’s news, the House…

Continue Reading Overnight Health Care: Biden team to begin getting COVID briefings | Fauci says he would ‘absolutely’ serve on Biden’s COVID task force | Major glove factories close after thousands test positive for COVID-19
Partnership links immunotherapy and AI

Building on a business relationship that was established in 2019, BioNTech SE and InstaDeep Ltd have struck a multi-year partnership that, companies say, will employ the most up-to-date developments in…

Continue Reading Partnership links immunotherapy and AI
CDC data: Abortion rates rise slightly

The abortion rate in the U.S. ticked up slightly from 2017 to 2018, according to data reported to the Centers for Disease Control and Prevention (CDC) by 47 states and New York…

Continue Reading CDC data: Abortion rates rise slightly
Rite Aid updates COVID-19 testing program

Rite Aid updates COVID-19 testing program Tue, 11/24/2020 - 19:00 cbaker_admin Wed, 11/25/2020 - 13:00 Rite Aid has revised its COVID-19 testing program, in conjunction with HHS, to include all…

Continue Reading Rite Aid updates COVID-19 testing program
Thanksgiving Break 2020

So I’ll be taking time off until probably Monday, unless we get any big news. Thanksgiving season is here, and although we don’t have as big a crowd as usual…

Continue Reading Thanksgiving Break 2020
Biden team to begin getting COVID-19 briefings

The Biden transition team will begin receiving briefings from federal agencies Wednesday on the COVID-19 response, Biden officials said Wednesday. The transition team has requested briefings on the COVID-19 vaccine distribution,…

Continue Reading Biden team to begin getting COVID-19 briefings
What, Us Worry

By KIM BELLARD 2020 has been an awful year.  Hurricanes, wildfires, murder hornets, unjustified shootings, a divisive Presidential election, and, of course, a pandemic.  Most of us are spending unprecedented…

Continue Reading What, Us Worry
Advarra acquires Longboat

The clinical site services provider continues its series of strategic company purchases by bringing the Irish trial technologies firm under its umbrella.

Continue Reading Advarra acquires Longboat
New mechanism of pain control revealed

Researchers have identified a unique population of astrocytes in the dorsal horn of the spinal cord of mice that produces pain hypersensitivity when activated by neurons carrying signals down from…

Continue Reading New mechanism of pain control revealed
How Surgeons Use VR Technology to Train and Adapt

Surgical training platforms that leverage virtual reality can provide immersive education for students and surgeons to evolve the skill sets required for advanced medical procedures. Lifelike visuals and tactile feedback…

Continue Reading How Surgeons Use VR Technology to Train and Adapt
WHO: Pandemic has slowed down in Europe

The rate of the coronavirus pandemic in Europe has slowed over the past week despite increasing death rates, the World Health Organization (WHO) said on Wednesday.The agency said that even…

Continue Reading WHO: Pandemic has slowed down in Europe
One of the oldest vaccines could help combat COVID-19

A new study has associated the Bacillus Calmette-Guérin (BCG) tuberculosis (TB) vaccine with reduced likelihood of contracting COVID-19. According to the researchers, this raises the possibility that a vaccine already…

Continue Reading One of the oldest vaccines could help combat COVID-19
EC approves new meningitis vaccine

The European Commission (EC) has approved MenQuadfi® for the active immunisation of individuals aged of 12 months and older against invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W and Y.…

Continue Reading EC approves new meningitis vaccine
Alliance and Boots donate dexamethasone to NHS

The UK’s largest medical wholesaler and pharmacy have donated half a million dexamethasone tablets to support the effort against COVID-19. Alliance Healthcare and Boots, both part of Walgreens Boots Alliance,…

Continue Reading Alliance and Boots donate dexamethasone to NHS
Alvotech and Alvotech & CCHT Sign an Exclusive Commercialization Agreement with Yangtze River for Eight Biosimilars in China

Shots: The companies collaborate with the Yangtze to commercialize eight biosimilars in China. The initial pipeline contains biosimilar candidates for the treatment of autoimmunity, ophthalmology, and oncologyAlvotech and Alvotech &…

Continue Reading Alvotech and Alvotech & CCHT Sign an Exclusive Commercialization Agreement with Yangtze River for Eight Biosimilars in China
Digitally engaging doctors around the world

Pharmaceutical marketing budgets are going through a period of readjustment as companies explore and exploit a myriad of different digital channels to deliver content to, and engage with, their doctors…

Continue Reading Digitally engaging doctors around the world
Alnylam’s Oxlumo (lumasiran) Receives the US FDA’s Approval for Treatment of Primary Hyperoxaluria Type 1 in Pediatric and Adult Patients

Shots: The approval is based on P-III ILLUMINATE-A & -B trials. The studies demonstrating reductions in urinary oxalate and encourage safety and tolerability in pediatric and adult patientsThe ILLUMINATE-A showed…

Continue Reading Alnylam’s Oxlumo (lumasiran) Receives the US FDA’s Approval for Treatment of Primary Hyperoxaluria Type 1 in Pediatric and Adult Patients
Gavisun Healthcare

  Gavisun Healthcare Pvt. Ltd. Address : Plot No 177,Industrial Area,Phase 1 Panchkula,Haryana - 134113 GAVISUN HEALTHCARE provides pharma third party manufacturing of over 500 products and covers all major…

Continue Reading Gavisun Healthcare
BMS’ Opdivo (nivolumab) Receives EC’s Approval as 2L Treatment for Unresectable Advanced and Metastatic Esophageal Squamous Cell Carcinoma

Shots: The approval is based on P-lll ATTRACTION-3 study involve the assessment of Opdivo vs CT (docetaxel or paclitaxel) for patients with esophageal cancer refractory/ intolerant to 1L combination therapy…

Continue Reading BMS’ Opdivo (nivolumab) Receives EC’s Approval as 2L Treatment for Unresectable Advanced and Metastatic Esophageal Squamous Cell Carcinoma
New patent for Dexcel Pharma drug OMEPRAZOLE

Annual Drug Patent Expirations for OMEPRAZOLE Omeprazole is a drug marketed by Actavis Labs Fl Inc, Apotex, Aurobindo Pharma Ltd, Breckenridge, Dr Reddys Labs Ltd, Glenmark Generics, Hetero Labs Ltd……

Continue Reading New patent for Dexcel Pharma drug OMEPRAZOLE
New patent for Allergan drug FETZIMA

Annual Drug Patent Expirations for FETZIMA Fetzima is a drug marketed by Allergan and is included in one NDA. It is available from one supplier. There are three patents protecting……

Continue Reading New patent for Allergan drug FETZIMA
A vaccine revolution | podcast

Results from clinical trials have shown that the world has three apparently highly effective vaccines for Covid-19. With the race now on for regulatory approval, production and distribution, is the…

Continue Reading A vaccine revolution | podcast
Overnight Health Care: White House coronavirus task force says ‘significant behavior change’ needed of Americans | HHS working with Biden on transition | 6.4 million COVID-19 vaccine doses expected to be shipped to states by mid-December

Welcome to Tuesday’s Overnight Health Care.The White House coronavirus task force says Americans need to significantly change their behavior to reduce COVID-19 cases, hospitalizations and deaths. States could receive the…

Continue Reading Overnight Health Care: White House coronavirus task force says ‘significant behavior change’ needed of Americans | HHS working with Biden on transition | 6.4 million COVID-19 vaccine doses expected to be shipped to states by mid-December

End of content

No more pages to load